{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJ6fg7wLDA","lastupdate":"2022-11-01T00:00:00.000Z","update_date":"2022-11-01T00:00:00.000Z","lastModified":"Feb 26, 2025","active":1,"confidence_score":92,"confidence_score_reason":"markets, not claimed","urlname":"biological-industries","minimal_profile":null,"status":"Acquired","fullstatus":"Acquired by Sartorius on May, 2019","acquired":1,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$c7sRSL8klUB9MAXyMIay9k8utko60Vi6gADChPGB4AjubTApcjcjyG","name":"Biological Industries","oneliner":"Tissue Culture Products for Research and Diagnostics","registrar":"511513145","website":"https://www.sartorius.com/en/pr/biological-industries","careerspage":"","founded_month":12,"founded_year":1990,"formernames":[],"sociallinks":{"twitter":"https://twitter.com/bio_industries","youtube":"https://www.youtube.com/user/BiologicalIndustries","facebook":"https://www.facebook.com/bioind","linkedin":"https://www.linkedin.com/company/1902252","instagram":""},"social":["https://www.facebook.com/bioind","https://www.youtube.com/user/BiologicalIndustries","https://www.linkedin.com/company/1902252","https://twitter.com/bio_industries"],"flattenedsociallinks":"https://www.facebook.com/bioind|https://www.youtube.com/user/BiologicalIndustries|https://www.linkedin.com/company/1902252|https://twitter.com/bio_industries","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":null,"employees":"51-200","employees_exact":58,"patent":0,"raised":0,"stage":"Acquired","public_stage":"Acquired","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["BI","Biological Industries Israel Beit-Haemek Ltd."],"about":"Biological Industries is a global supplier for the life sciences industry. With over 30 years' experience in cell culture media development and manufacturing, the company has supplied products to and collaborated with a wide range of academic institutions and biotechnology companies.\n\nBiological Industries' products include cell culture media, supplements, reagents for stem cell research and potential cell therapy applications, and serum-free media. In addition to its advanced manufacturing and quality control systems, the company has regulatory experience, in-depth market knowledge, and extensive training and R&D capabilities.\n\nThe company supplies life science products to the biopharmaceutical industry, universities, government research organizations, and healthcare institutions.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+97249960595","country":null,"address":{"israeli":[{"id":"9dafe91e-d63b-49cd-b2cd-14f5a5d8e0d9","city":"Beit HaEmek","type":null,"address":"Beit HaEmek, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":[{"id":"2202fbb9-abc5-4b2e-9cdc-e5b61fbcb286","city":"Cromwell","address":"100 Sebethe Drive, Cromwell, CT, USA","country":"United States","placeid":null}]},"headquarter_address":null,"district":"North District","news":[{"id":"O5NoPD3roWxI04FfsQCRU7PvQ1anoSyoTGlRnto5dlteKKL08Mm9WH","date":"Dec 5, 2019","link":"https://www.businesswire.com/news/home/20191205005479/en/Sartorius-Acquires-a-Majority-Stake-in-Cell-Culture-Media-Specialist-Biological-Industries","source":"www.businesswire.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"ypfOm4vsY0UaBYoNPQGZNusRNgLUcK4T7LRD4490nQm3HfACKVKU0O","news_summary":"Sartorius Acquires a Majority Stake in Cell Culture Media Specialist Biological Industries","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"e09a09af-ca23-492e-9ebd-7dfb1e7f12cf","date":"Jun 7, 2018","link":"http://www.hartfordbusiness.com/article/20180607/NEWS01/180609912/cromwell-life-sciences-firm-inks-distribution-deal","source":"www.hartfordbusiness.com","visible":1,"analysis":{"tags":"distribution partnership","company":"Cromwells Biological Industries","layoffs":null,"summary":"Cromwells Biological Industries has entered into a distribution partnership with Primorigen, a Wisconsin company, to distribute Primorigens protein matrix for stem cell culture called Vitronectin XF. The financial terms of the deal were not disclosed. This partnership will allow the scientific community to leverage the benefits of Vitronectin XF.","partners":["Primorigen"],"customers":null,"investors":null,"confidence":8,"key_topics":["cell culture media","distribution partnership","Primorigen","Vitronectin XF","stem cell culture"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"B8v8W9bhUR0bahHL3d5VQyRPW0mNbG2S952FDQm2Fdtc17IJmNz01A","news_summary":"Cromwell life sciences firm inks distribution deal","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"0642387f-7b97-46c3-b2f7-4d071f1e4dbc","date":"Jun 6, 2018","link":"https://www.businesswire.com/news/home/20180606006187/en/Biological-Industries-USA-Adds-Vitronectin-XF%E2%84%A2-Stem","source":"www.businesswire.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"yrX4q6WcWnzbqWIW9Y97wsrg7BRxeqojUVC5TBa2OxqLaBmNtcGI4u","news_summary":"Biological Industries USA Adds Vitronectin XF™ to its Stem Cell Portfolio Through Agreement with Primorigen Biosciences, Inc.","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"8c2ed25d-a428-4df7-ad9f-ac1ba90a00eb","date":"May 9, 2018","link":"https://www.businesswire.com/news/home/20180509005429/en/Biological-Industries-USA-Announces-Initial-Winners-MSC","source":"www.businesswire.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"ngVc93uRw0258a7aSAHNNWKAM8KKXVzKFwPwxGAYVBT6cDT4Me7ybO","news_summary":"Biological Industries USA Announces Initial Winners of MSC Research Awards","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"6b42097e-b572-4ab3-a996-ab04b1c155e6","date":"Jan 23, 2018","link":"https://www.businesswire.com/news/home/20180123005151/en/Biological-Industries-USA-Announces-Mesenchymal-Stromal-Stem","source":"www.businesswire.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"wIRdKsUiWIMbfjpdY5xLKTcenlu5Nt9WpgFouVlENPuYoYk2dWegHb","news_summary":"Biological Industries USA Announces Mesenchymal Stromal and Stem Cell Research Award, Including Conference Travel, Laboratory Reagents, and Potential Publicity for Researchers","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"c97bab9b-c16c-4f04-8cfa-e8c6c65454ce","date":"Mar 6, 2017","link":"http://blog.bioind.com/biological-industries-usa-signs-agreement-mill-creek-life-sciences-add-pltmax-human-platelet-lysate-growing-stem-cell-portfolio/","source":"blog.bioind.com","visible":1,"analysis":{"tags":"distribution agreement","company":"Biological Industries USA","layoffs":null,"summary":"Biological Industries USA (BI-USA) has announced a distribution agreement with Mill Creek Life Sciences LLC for the distribution of PLTMax® Human Platelet Lysate. This product offers superior growth and cellular properties for the culture of human mesenchymal stem cells. The agreement allows BI-USA to expand its stem cell portfolio reach in the US and beyond. The partnership aims to serve the needs of the stem cell industry through application development. Mill Creek Life Sciences provides tools to support the development and application of cellular and biological therapeutics. The agreement is expected to have a positive impact on the growth of Biological Industries USA.","partners":"Mill Creek Life Sciences LLC","customers":null,"investors":null,"confidence":9,"key_topics":["PLTMax","NutriStem MSC Medium","distribution agreement","stem cell industry","cell culture media"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"VBZLkCZnkWBcBBJ7cfAGvlB7J33a6WfIh33buwf0s2h0jjFatebAfj","news_summary":"Biological Industries USA Signs Agreement With Mill Creek Life Sciences To Add PLTMax Human Platelet Lysate To Its Growing Stem Cell Portfolio - Biological Industries","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"dd6b3d2f-a859-41d2-b88f-7c844b419b86","date":"Sep 16, 2013","link":"http://www.flowerweb.com/en/article/169707/Long-term-agreement-between-Bartels-Stek-and-Biological-Industries-%28Israel%29-regarding-Gypsophila","source":"www.flowerweb.com","visible":1,"analysis":{"tags":"distribution agreement","company":"Bartels Stek","layoffs":null,"summary":"Bartels Stek and Biological Industries Ltd (BI) have signed a long-term agreement for the exclusive worldwide distribution of all Gypsophila varieties by Bartels Stek. Bartels Stek will handle worldwide sales, license, and marketing activities for all Gypsophila varieties of BI, except for Israel. The agreement is expected to improve BIs worldwide distribution and benefit growers around the world. Bartels Stek specializes in perennial and fillers, and Gypsophila will be a great addition to their range of filler crops. The teams of BI and Bartels Stek will work closely together to offer customers the best possible service. Testing of all selections will take place in Israel and Kenya.","partners":"Biological Industries Ltd (BI)","customers":null,"investors":null,"confidence":8,"key_topics":["distribution agreement","Gypsophila varieties","worldwide sales","technical support","breeding"],"date_of_event":"2013-09-16","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"T5TLi4AfzuiWP5rGuq0EbeIC47zIygShSZrcI5bCP2Dh5JR9UnOtxm","news_summary":"Long term agreement between Bartels Stek and Biological Industries (Israel) regarding Gypsophila","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":7,"techcommunityinvolvement":null,"mediagallery":[{"id":"ebf5279e-f746-4e05-b392-52ba7e6a5657","timestamp":"2019-02-18 11:17:10.000000","resources_type":2,"resources_title":"","resources_file_name":"wGTKN30VL5g","alt":"","imageurl":"https://img.youtube.com/vi/wGTKN30VL5g/0.jpg","url":"http://youtu.be/wGTKN30VL5g"},{"id":"17d06540-cc3e-4614-8888-f0ff75e56131","timestamp":"2019-02-18 11:15:20.000000","resources_type":1,"resources_title":"","resources_file_name":"$srz0X9IGYnVcQcDIgoOH4BisA8Pndr9De1VNTB7QuXje3CtKZJu3Vu","alt":"","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$srz0X9IGYnVcQcDIgoOH4BisA8Pndr9De1VNTB7QuXje3CtKZJu3Vu","url":"https://storage.googleapis.com/clean-finder-353810/$srz0X9IGYnVcQcDIgoOH4BisA8Pndr9De1VNTB7QuXje3CtKZJu3Vu"},{"id":"5d88420e-8b59-4701-be00-1b1898e49398","timestamp":"2016-03-10 10:28:03.000000","resources_type":1,"resources_title":"","resources_file_name":"$V3Hp4ZtmQBuGbGGeW3PjXOcThOi3zQnitjlSe0ZkT6ppScvQTJ6rox","alt":"","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$V3Hp4ZtmQBuGbGGeW3PjXOcThOi3zQnitjlSe0ZkT6ppScvQTJ6rox","url":"https://storage.googleapis.com/clean-finder-353810/$V3Hp4ZtmQBuGbGGeW3PjXOcThOi3zQnitjlSe0ZkT6ppScvQTJ6rox"}],"tags":["bioprocess","cell-therapy","stem-cells","molecular-biology","pharma-companies"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4MeNluQIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7vMIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA"],"technologysuccessstory":[{"date":"1990-12-01","name":"Supplying healthcare institutions with life science products","tags":["stem-cells","life-sciences"],"category":"Life Sciences & Biotechnology","tto_logo":"/image_cloud/tel-hashomer_tto_logo_5471b6e8-b5d5-11e8-8a10-c14be16af9ea","university_logo":"/image_cloud/tel-hashomer_institution_logo_5471b6e8-b5d5-11e8-8a10-c14be16af9ea"}],"usecases":[],"businessmodels":["B2B"],"productstage":"Released","products":["NutriFreez","AquaGuard","EZ-PCR","MSCgo","NutriStem","EndoGo","NutriVero","Pharmacidal","BIOTARGET","BIOMYC","BIO-HEMATO","BIO-AMF"],"geomarkets":["Global"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":0,"lastfunding":"Undisclosed","totalrounds":0,"fundingstage":"Acquired","totalfunding":"Undisclosed","publicinvestors":0,"lastpublicfunding":null,"totalpublicrounds":0,"totalpublicfunding":0},"team":[{"name":"Anat Elbaz","email":"anat@bioind.com","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoMXDy4sKDA","bounced":true,"claimed":0,"founder":0,"urlname":"anat-elbaz","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICg5Z6q3gsM","position":"HR Manager","last_name":"Elbaz","claimtoken":"7b4c8c4125c211cb9e09131cf9e2138c3c24e649d371b80a13b96760cdeb655e","first_name":"Anat","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/anat-elbaz-02267880/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2020-08-25 06:47:20.000000","initials":"AE","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Pharmaceuticals","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgPGylJ0IDA","fullname":"Natalia Golczar"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgLHD0KwIDA","fullname":"Sharon Shapira"},"biverifydate":"2019-10-29T00:00:00.000Z","crunchbaseid":"biological-industries-ltd","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":null,"creator_email":null,"createdate":"2014-11-12T00:00:00.000Z","biverification":"Sharon Shapira","sectorverification":"Natalia Golczar","affiliatedOrganizations":null,"timeline":[{"id":"wPbf15bXkXZ0jPNOw7vdoxiFUAJZUXBpfDWZcRLbBtc0vf0VN24JAn","date":"May 2019","amount":"Undisclosed","source":"https://www.businesswire.com/news/home/20191205005479/en/Sartorius-Acquires-a-Majority-Stake-in-Cell-Culture-Media-Specialist-Biological-Industries","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":1,"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"acquiredcompany_mna":"Sartorius","acquiredcompany_mna_id":"ZUaa0QfEBFsXbZZwmhXWmAL2LTq46OMh4ipEVzg0JpVCfAbxuPf5Zx","acquiredcompany_mna_type":"Company","acquiredcompany_mna_hidden":true,"acquiredcompany_mna_fullurl":"/company_page/sartorius","acquiredcompany_mna_logokey":"$yYLv0tWwKzfNUzYnj160yMcOmkkrJ0swRr98QS0V4OOefT3DOnr0kx","acquiredcompany_mna_urlname":"/company_page/sartorius","acquiredcompany_mna_homepage":null,"style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$yYLv0tWwKzfNUzYnj160yMcOmkkrJ0swRr98QS0V4OOefT3DOnr0kx","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"12/1990","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Biological Industries","logourl":"https://storage.googleapis.com/clean-finder-353810/$c7sRSL8klUB9MAXyMIay9k8utko60Vi6gADChPGB4AjubTApcjcjyG","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$c7sRSL8klUB9MAXyMIay9k8utko60Vi6gADChPGB4AjubTApcjcjyG","seoabout":"Biological Industries is a global supplier for the life sciences industry. With over 30 years' experience in cell culture media development and manufacturi...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":1,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Biomaterials & Tissue Engineering","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4MeNluQIDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":2,"name":"Cells","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7vMIDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"},{"depth":3,"name":"Biotechnology","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Biomaterials & Tissue Engineering#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4MeNluQIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA>Cells#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7vMIDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Biomaterials & Tissue Engineering#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4MeNluQIDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA|2:>TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA/Cells#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7vMIDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Pharma & Medical Biotechnology","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology","children":[{"title":"Biomaterials & Tissue Engineering","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Biomaterials & Tissue Engineering"}]},{"title":"Medical Devices","key":"0-0-1","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices"}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Life Sciences","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences","children":[{"title":"Pharmaceuticals","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Pharmaceuticals"},{"title":"Biotechnology","key":"0-0-0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Biotechnology"}]}]}],"coreTechnology":[{"title":"Biologicals","key":"0-0","path":"TechnologyClassificationModel>Biologicals","children":[{"title":"Cells","key":"0-0-0","path":"TechnologyClassificationModel>Biologicals>Cells"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Biomaterials & Tissue Engineering","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4MeNluQIDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":2,"name":"Cells","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7vMIDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"},{"depth":3,"name":"Biotechnology","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Pharma & Medical Biotechnology","Biomaterials & Tissue Engineering","Medical Devices"],"coreTechnology":["Biologicals","Cells"],"targetCustomer":["Healthcare & Life Sciences","Life Sciences","Pharmaceuticals","Biotechnology"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[{"id":"wPbf15bXkXZ0jPNOw7vdoxiFUAJZUXBpfDWZcRLbBtc0vf0VN24JAn","date":"May 2019","amount":"Undisclosed","source":"https://www.businesswire.com/news/home/20191205005479/en/Sartorius-Acquires-a-Majority-Stake-in-Cell-Culture-Media-Specialist-Biological-Industries","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":1,"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"acquiredcompany_mna":"Sartorius","acquiredcompany_mna_id":"ZUaa0QfEBFsXbZZwmhXWmAL2LTq46OMh4ipEVzg0JpVCfAbxuPf5Zx","acquiredcompany_mna_type":"Company","acquiredcompany_mna_hidden":true,"acquiredcompany_mna_fullurl":"/company_page/sartorius","acquiredcompany_mna_logokey":"$yYLv0tWwKzfNUzYnj160yMcOmkkrJ0swRr98QS0V4OOefT3DOnr0kx","acquiredcompany_mna_urlname":"/company_page/sartorius","acquiredcompany_mna_homepage":null,"style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$yYLv0tWwKzfNUzYnj160yMcOmkkrJ0swRr98QS0V4OOefT3DOnr0kx","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"privateequityfunding":[],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}